Hiroaki Itamochi

8PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)PharmacogenomicsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2026
Pulmonary Artery Intimal Sarcoma Successfully Treated With Surgery and Adjuvant Chemotherapy: A Case Report.

|Jan 05, 2025
Comprehensive Genome Profiling-Initiated Tumor-Informed Circulating Tumor DNA Monitoring for Patients With Advanced Cancer.

Taiga Sasaki, Hayato Hiraki, Akiko Yashima-Abo

|Jul 26, 2024
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi

|Sep 02, 2022
Primary rhabdomyosarcoma of the ethmoid sinus with orbital extension and metastasis to the pancreatic body.

Hiroaki Itamochi, Hisanori Ariga, Kiyoto Shiga

|Jul 06, 2022
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.

Shin Nishio, Kan Yonemori, Tomoka Usami

|Jan 20, 2021
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi

Pageof 2

Frequent Collaborators

3 joint publications

Kosei Hasegawa

2 joint publications

Hidemichi Watari

2 joint publications

Hideki Tokunaga

2 joint publications

Kazuhiro Takehara